Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

Agency to repeal in-person dispensing requirement to receive mifepristone; requirement has been temporarily suspended during pandemic

Washington, D.C. — Today, the U.S. Food and Drug Administration (FDA) announced a permanent repeal of the in-person dispensing requirement for mifepristone, one of two medications used in a medication abortion. The requirement — part of a set of unnecessary restrictions known as the Risk Evaluation and Mitigation Strategy (REMS) — mandates that patients obtain the medication in person at a doctor’s office, hospital, or health center instead of from a pharmacy or by mail, which is allowed for other equally safe medications. 

Amid widespread social distancing provisions during the pandemic health emergency, the FDA temporarily suspended this requirement last Spring. A patient's unnecessary in-person visits  risks exposure to COVID-19 through transportation, child care, multiple health center trips, and more. Today’s decision comes after the FDA conducted a full review on the set of restrictions. However, the FDA left a few medically unnecessary restrictions on medication abortion in place. 

Statement from Alexis McGill Johnson, president & CEO, Planned Parenthood Federation of America:

“Today’s news is a victory for public health and health equity. Let’s be clear: The FDA followed the science in arriving at this decision. There is overwhelming evidence that medication abortion can be safely and effectively provided through telehealth. We’ve seen very clearly in the past two years that the logistical hurdle of unnecessary travel to health centers during a dangerous pandemic only creates more barriers to care, especially for people of color and people with low incomes. Abortion is time-sensitive, essential health care, and this decision will remove a sometimes insurmountable barrier for patients seeking an abortion. With abortion rights at risk like never before, the FDA’s decision is a long overdue step toward expanding people’s access to safe medication abortion.”

Right now the constitutional right to abortion is at a crisis point across the country, as the U.S. Supreme Court considers a case that could overturn Roe v. Wade. Steps like today’s FDA decision are critical for maintaining and expanding access to medication abortion. The FDA’s decision is one way to make it easier for patients to access care. 

Mifepristone is safe, effective, and has been used by more than 4 million people since the FDA approved it more than 20 years ago. Leading medical associations, such as the American College of Obstetricians and Gynecologists and American Academy of Family Physicians, have maintained that the FDA’s long-standing restrictions on mifepristone are not based on evidence and do not benefit patients. In fact, out of 20,000 prescription medications regulated by the FDA, mifepristone is the only home-use medication required to be dispensed in person. Mifepristone has helped ensure that patients can make their own private medical decisions, and it has expanded access to essential, time-sensitive reproductive health care.

Planned Parenthood is proud to offer medication abortion via telehealth in 21 states. As a leading sexual and reproductive health care provider, Planned Parenthood is committed to making sure all patients receive the high-quality health care they need, when they need it — including safe, legal abortion. By providing medication abortion safely and effectively via telehealth, we can keep patients, providers, and health center staff safer during the pandemic and expand access to abortion for people, no matter where they live.


Planned Parenthood is the nation’s leading provider and advocate of high-quality, affordable sexual and reproductive health care, as well as the nation’s largest provider of sex education. With more than 600 health centers across the country, Planned Parenthood organizations serve all patients with care and compassion, with respect and without judgment. Through health centers, programs in schools and communities, and online resources, Planned Parenthood is a trusted source of reliable health information that allows people to make informed health decisions. We do all this because we care passionately about helping people lead healthier lives.


This website uses cookies

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of required cookies when utilizing our site; this includes necessary cookies that help our site to function (such as remembering your cookie preference settings). For more information, please see our Privacy Notice.



We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.



We use qualitative data, including session replay, to learn about your user experience and improve our products and services.



We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.